These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

583 related items for PubMed ID: 24748537

  • 1. Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults.
    Holtick U, Albrecht M, Chemnitz JM, Theurich S, Skoetz N, Scheid C, von Bergwelt-Baildon M.
    Cochrane Database Syst Rev; 2014 Apr 20; 2014(4):CD010189. PubMed ID: 24748537
    [Abstract] [Full Text] [Related]

  • 2. Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults.
    Kiene S, Albrecht M, Theurich S, Scheid C, Skoetz N, Holtick U.
    Cochrane Database Syst Rev; 2024 Nov 07; 11(11):CD010189. PubMed ID: 39508306
    [Abstract] [Full Text] [Related]

  • 3. Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults.
    Theurich S, Fischmann H, Shimabukuro-Vornhagen A, Chemnitz JM, Holtick U, Scheid C, Skoetz N, von Bergwelt-Baildon M.
    Cochrane Database Syst Rev; 2012 Sep 12; (9):CD009159. PubMed ID: 22972135
    [Abstract] [Full Text] [Related]

  • 4. Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft-versus-host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition.
    Fisher SA, Cutler A, Doree C, Brunskill SJ, Stanworth SJ, Navarrete C, Girdlestone J.
    Cochrane Database Syst Rev; 2019 Jan 30; 1(1):CD009768. PubMed ID: 30697701
    [Abstract] [Full Text] [Related]

  • 5. Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults.
    Chakupurakal G, Freudenberger P, Skoetz N, Ahr H, Theurich S.
    Cochrane Database Syst Rev; 2023 Jun 21; 6(6):CD009159. PubMed ID: 37341189
    [Abstract] [Full Text] [Related]

  • 6. Allogeneic bone marrow transplantation compared to peripheral blood stem cell transplantation for the treatment of hematologic malignancies: a meta-analysis based on time-to-event data from randomized controlled trials.
    Chang YJ, Weng CL, Sun LX, Zhao YT.
    Ann Hematol; 2012 Mar 21; 91(3):427-37. PubMed ID: 21789620
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Allogeneic peripheral blood stem cell and bone marrow transplantation for hematologic malignancies: meta-analysis of randomized controlled trials.
    Zhang H, Chen J, Que W.
    Leuk Res; 2012 Apr 21; 36(4):431-7. PubMed ID: 22050904
    [Abstract] [Full Text] [Related]

  • 9. Allogeneic transplantation of bone marrow versus peripheral blood stem cells from HLA-identical sibling donors for hematological malignancies in 6064 adults from 2003 to 2020: different impacts on survival according to time period.
    Konuma T, Miyao K, Nakasone H, Ouchi F, Fukuda T, Tanaka M, Ozawa Y, Ota S, Kawakita T, Uchida N, Sawa M, Katayama Y, Hiramoto N, Eto T, Ichinohe T, Atsuta Y, Kanda J, Donor/Source Working Group of the Japanese Society for Transplantation and Cellular Therapy.
    Cytotherapy; 2024 Aug 21; 26(8):910-920. PubMed ID: 38639671
    [Abstract] [Full Text] [Related]

  • 10. Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support.
    Radford M, Estcourt LJ, Sirotich E, Pitre T, Britto J, Watson M, Brunskill SJ, Fergusson DA, Dorée C, Arnold DM.
    Cochrane Database Syst Rev; 2024 May 23; 5(5):CD011305. PubMed ID: 38780066
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparable outcomes of allogeneic peripheral blood versus bone marrow hematopoietic stem cell transplantation from a sibling donor for pediatric patients.
    Kim BK, Hong KT, Choi JY, Kim H, Park HJ, Kang HJ.
    Ann Hematol; 2024 Jun 23; 103(6):2051-2058. PubMed ID: 38594416
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P.
    Cochrane Database Syst Rev; 2022 Feb 01; 2(2022):. PubMed ID: 36321557
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis.
    Cutler C, Giri S, Jeyapalan S, Paniagua D, Viswanathan A, Antin JH.
    J Clin Oncol; 2001 Aug 15; 19(16):3685-91. PubMed ID: 11504750
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of transplant outcomes from matched sibling bone marrow or peripheral blood stem cell and unrelated cord blood in patients 50 years or older.
    Konuma T, Tsukada N, Kanda J, Uchida N, Ohno Y, Miyakoshi S, Kanamori H, Hidaka M, Sakura T, Onizuka M, Kobayashi N, Sawa M, Eto T, Matsuhashi Y, Kato K, Ichinohe T, Atsuta Y, Miyamura K, Donor/Source Working Group of the Japan Society for Hematopoietic Cell Transplantation.
    Am J Hematol; 2016 May 15; 91(5):E284-92. PubMed ID: 26910296
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.